Company intelligence / Profile preview

Sontag Innovation Fund

Ponte Vedra Beach, Florida, USA

Ownership: Private
Development stage: Other

Overview

Sontag Innovation Fund invests in early-stage companies developing therapeutics, diagnostics, and devices to treat, diagnose, prevent, and cure brain cancer. Portfolio company Modifi Biosciences, acquired by Merck in 2024, validated the fund's investment thesis with potential for significant impact in brain cancer treatment development.

Therapeutic areas: Oncology
Modalities: Small moleculeAntibodyBiologicDiagnostic deviceMedical device
Industry: Investors

Partnerships

Critical Path Institute Translational Therapeutics Accelerator (TRxA)

Beyond the preview

Go deeper on Sontag Innovation Fund.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sontag Innovation Fund.

Explore the full profile